Cleared Traditional

ABCcolla Bone Matrix (K212156) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K212156 · Acro Biomedical Co., Ltd. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2021
Decision
88d
Days
Class 2
Risk

K212156 is an FDA 510(k) clearance for the ABCcolla Bone Matrix. Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.

Submitted by Acro Biomedical Co., Ltd. (Kaohsiung, TW). The FDA issued a Cleared decision on October 8, 2021 after a review of 88 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Acro Biomedical Co., Ltd. devices

Submission Details

510(k) Number K212156 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 12, 2021
Decision Date October 08, 2021
Days to Decision 88 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
34d faster than avg
Panel avg: 122d · This submission: 88d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MQV Filler, Bone Void, Calcium Compound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MQV Filler, Bone Void, Calcium Compound

All 201
Devices cleared under the same product code (MQV) and FDA review panel - the closest regulatory comparables to K212156.
Osteorevive
K212991 · Bone Solutions, Inc. · Jan 2022
MagnetOs granules
K213111 · Kuros Biosciences B.V · Jan 2022
PRO-DENSE LoVisc Bone Graft Substitute
K213342 · Wrightmedicaltechnologyinc · Jan 2022
Dry DBM- A Putty
K212135 · Seaspine Corporation · Oct 2021
DB-EZ Bone Void Filler
K212353 · Dimensional Bioceramics, LLC · Sep 2021
MagnetOs Easypack Putty
K211201 · Kuros Biosciences B.V · Sep 2021